View
232
Download
6
Category
Preview:
Citation preview
MagneticMaharashtra
Attractions Unlimited
Maharashtra –Pharmaceutical SectorNovember 2014
www.midcindia.org
Knowledge Partner
MagneticMaharashtra
Attractions Unlimited
Preface
§ The Maharashtra Pharmaceutical Sector Profile has been developed by Ernst & Young India LLP, the Knowledge Partner to Maharashtra IndustrialDevelopment Corporation to provide hand holding assistance to investors.
§ The intention is to provide executives a quick overview to the Pharmaceutical Sector in the State.
§ The complex decision-making process involved in undertaking foreign operations requires an intimate knowledge of a country’s and a State’s commercialclimate as well as recognition of the fact that this climate is continuously evolving. Companies doing business in India, or planning to do so, would be well-advised to obtain current and detailed information from experienced professionals. The information presented in this book has been validated w.e.fSeptember 2014.
Knowledge Partner
2
7.58.6
10.412.0
13.7
2008-09 2009-10 2010-11 2011-12 2012-13
Maharashtra's GSDP in INR Lakh Crore
Macroeconomic Profile- Economy
§ The manufacturing sector contributes a significant 18.51 per cent to the state’s GSDP. Amongst the 10 states with the highest GSDP (GrossState Domestic Product) in India, Maharashtra is one of the leading states in terms of contribution of manufacturing share to the GSDP.
§ Maharashtra has a Per Capita Income (PCI) of INR 1,07,670. The state has the highest per capita income amongst the 10 states with the highestGSDP in India.
8.43%
LEADER
Maharashtra has thehighest GSDP inIndia – INR 13.7 LakhCrore (USD 228.3Billion)
CAGR of GSDP atconstant prices overthe last 5 years
MagneticMaharashtra
Attractions Unlimited
3
5.206.00 6.24
7.85
10.05
2007-08 2008-09 2009-10 2010-11 2011-12
Maharashtra's Industrial Output in INR Lakh Crore
Macroeconomic Profile- Industry
§ The state recorded the highest Industrial Value Addition in the nation. The Gross Value Added by all industries in the state amounted to INR 1,79,222crore (USD 29.87 billion) in the year 2011-12, which is 59 per cent greater than the value addition of its closest follower.
§ Maharashtra has the second highest number of factories and has one of the lowest number of industrial disputes in the country.
17.41%
LEADER
Highest IndustrialOutput in the nation– INR 10.05 LakhCrore (USD 167.5Billion)
Maharashtra’s sharein India’s totalIndustrial Output
MagneticMaharashtra
Attractions Unlimited
4
Macroeconomic Profile- Investments
§ Maharashtra has attracted INR 3,16,082 crore of FDI over the period 2000- 2014, which is almost one-third of the nation’s total FDI inflows receivedover the same period.
§ New investment projects announced in 2013-14 which would be set in Maharashtra are proposed to bring in INR 27,795 crore of investment in the state.
§ In 2013-14, the state contributed 10.86 per cent of the total projects completed in India in terms of investment value. With a total of INR 28,406 crore ofinvestment projects completed in the state, Maharashtra is one of the leading states in the country in terms of project completion (by investment value).
One -Third
LEADERHighest FDI Inflowsin the nation
Maharashtra’s sharein India’s FDI Inflowsover the period 2000- 2014
27,669
44,664 47,359
2010-11 2011-12 2012-13
Maharashtra FDI Inflows in INR Crore
MagneticMaharashtra
Attractions Unlimited
5
ROAD AND RAILWAYS§ More than 99 per cent of the villages are well connected with all
weather roads in the state§ 9.3 percent of total railway network in the country§ 2 Major Railway zones§ Dry Ports, Inland Container Depots, Truck terminals and Railway
sidings for easy freight movement
AIR AND WATER PORTS§ 4 International and 7 Domestic Airports§ 6 MIDC airstrips§ 2 Major ports§ 22.45 per cent of the total cargo traffic of the major ports in India is
handled by the Jawaharlal Nehru Port (JNPT) and Mumbai Port(MBPT)
§ 53 Minor ports
LAND§ Maharashtra is the second largest state in India, with an area of 30
Million Hectares (307,713 sq. km.)§ MIDC has one of the largest land banks in India, with ‘industrial land’
spanning over 84,000 hectares
ENERGY§ Gross installed capacity of power plants (excluding Central Sector) is
23,726.7 MW. The state has the highest Gross installed capacity(Utilities) at 10.62 per cent of the nation’s total installed capacity.
§ Gross Generation of power plants (excluding central sector) is at77,169.9 million KwH
MagneticMaharashtra
Attractions Unlimited
6
Infrastructure
Infrastructure
National Highway
Railway
MIDC Airstrips
Key Locations
International Airport
Proposed GasPipeline Network
Major Ports
To Goa
To Madhya PradeshTo Gujarat To Madhya Pradesh
Nanded
Solapur
Sangali
Nasik
Dhule
Wardha
Jalna
Sindhudurg
To Andhra Pradesh
ToChhattisgarh
To Karnataka
To Goa
Amravati
Osmanabad
LaturBeed
Gadchiroli
Gondia
Gangapur
·
Sinnar
Rajgurunagar
Dighi
Shirdi
Karad
Shirpur
To Andhra Pradesh
Ozhar
BaramatiPhaltan
Akola
JalgaonNagpur
Bhandara
YavatmalChandrapur
Kolhapur
Ratnagiri
Satara
Aurangabad
Ahmednagar
Thane
Mumbai
Pune
Raigarh
Juhu
Domestic Airports
MagneticMaharashtra
Attractions Unlimited
7
Pharmaceutical Sector in India
§ The Indian pharmaceuticals market grew at a CAGR of 17.0 per cent in 2012 from only USD 6 billion in 2005 and is expected to grow at a CAGR of 12.1 percent to reach USD 45 billion in 2020.
§ By 2020, India is expected to be within the top 3 pharmaceutical market by incremental growth and sixth largest market globally in absolute size.
MagneticMaharashtra
Attractions Unlimited
8
0
10
20
30
40
50
2005 2012 2020F
Revenue of Indian pharmaceutical industry(USD billion)
Revenue of Indian pharmaceutical industry(USD billion)
Pharmaceutical Sectorin Maharashtra
MagneticMaharashtra
Attractions Unlimited
9
§ Maharashtra accounts for approximately 18.4 per cent of the country’s pharmaceutical output by value.§ Major pharmaceutical units, such as Pfizer, Johnson and Johnson, GlaxoSmithKline, Abbott and Sun Pharmaceutical Industries, have presence in the
state.§ Major opportunities have emerged in the pharmaceutical sector, primarily, in the areas of contract research, contract manufacturing and clinical
trials.§ The state has a well-developed laboratory, research and development infrastructure, and a strong resource pool.§ Maharashtra has a strong R&D base with major centre as Bioresearch Centre, Bioinformatics Centre, Serum Institute etc.§ Maharashtra has 3,139 Pharmaceutical manufacturing units.§ The state has 445 government, government aided and unaided pharmaceutical institutes with a total intake capacity of 25318 students.
Category Major Clusters
Traditional Bulk Drug Clusters Mumbai, Tarapur, Aurangabad,Pune
Traditional FormulationsCluster Mumbai and Pune
Company Investment Employment
Nipro India Corporation Pvt. Ltd. 680.72 1033
Klockner Pentaplast India Pvt. Ltd. 300 200
Varroc Eng. Pvt. Ltd. 152 559
Grand Total 1132.72 1792
Pharmaceutical HubsIn Maharashtra
MagneticMaharashtra
Attractions Unlimited
Kurkumbh
Add. Patalganga
Lote Parshuram
10
Key Growth DriversMagneticMaharashtra
Attractions Unlimited
11
IndustrialInfrastructure Policy Support
Rising ExportOpportunities
Doing BusinessSupport
PharmaceuticalSector in
Maharashtra
Strong TalentPool
SocialInfrastructure
Access toForeign Markets
Strong DomesticDemand
StrategicLocation
Human Capital
SKILLED WORKFORCE§ The state has a literacy rate of 82.34% with a large base of skilled and
industrial labour§ The state has a total of 2298 technical institutions with an intake capacity of
4,49,121. It also houses 781 ITI (Industrial Training institutes) with an intakecapacity of 1,17,747.
§ The Govt. is promoting "Centers of Excellence", which will cover all aspectsof cutting edge research and development in emerging areas of life sciencesand technology
§ The state also has one of the Indian Institutes of Technology (IITs) at Powaiin Mumbai, part of the country's renowned network of engineering andtechnology institutions. IIT Mumbai has 13 departments and various centersfor R&D
§ Top universities in the state like the University of Mumbai, University ofPune, Nagpur University, Bhartiya Vidyapeeth etc. provide courses forgraduation/post graduation/ Phds in pharmacy
§ The state has 46 government and government aided institutes with a intakecapacity for 2474 students
§ With almost 13% of the total institutes, the pharmaceutical institutes have atotal enrolment of 51826
§ The state has 465 institutions (Diploma, Degree, PG) for Pharmaceuticalsciences with an enrolment of 51826
MagneticMaharashtra
Attractions Unlimited
12
State’s literacy rate isat 82.34% with a large
base of skilled andindustrial labor
Presence of "Centersof Excellence",
covering all aspects ofcutting edge researchand development inemerging areas of
technology
Presence of IndianInstitutes of
Technology (IITs) inMumbai
Policy SupportMagneticMaharashtra
Attractions Unlimited
TechnologyUpgradation Subsidy
Interest Subsidy Stamp DutyExemption
VAT + CSTAbatement
Electricity DutyExemption
Cleaner ProductionIncentives
Water EnergySubsidy
Water conservationIncentives
Royalty Exemption
Fixed Capital Investment Employment Location
DETERMINING FACTORS
13
Maharashtra Industrial Policy 2013-18FISCAL INCENTIVE BASKET
§ Greenfield investments in the pharmaceutical sector will be permitted up to 100% FDI under automatic route. Brownfield projects will be permitted up to100% FDI with FIPB approval
§ Budget 2010–2011 reduced the customs duty from 10% to 5% on imports of select life saving drugs, conjugate vaccine and Micafungin sodium for injection
§ Patent and proprietary medicines included under chapter 30 of the Customs Tariff Act, 1975 which are imported for retail sale are exempted from specialadditional duty
MagneticMaharashtra
Attractions Unlimited
Key Players
14
Industrial PresenceMagneticMaharashtra
Attractions Unlimited
Hospital, Public Health
Patented Products
Consumer Healthcare
Biologics, Vaccines
15
Growth StoriesMagneticMaharashtra
Attractions Unlimited
§ Wockhardt, headquartered in Mumbai, is a major player in theintegrated healthcare segment.
§ Its market presence covers formulations, biopharmaceuticals,nutrition products, vaccines and active pharmaceutical ingredients(APIs).
§ In 2012-13, the company had earned revenues of USD 1.03 billion.
§ It has set up a global-scale biopharmaceuticals manufacturing park,the Wockhardt Biotech Park, in Aurangabad. This state-of-the-artcomplex comprises six dedicated manufacturing facilities, and isdesigned according to USFDA and EMEA standards.
§ The company’s manufacturing plants in Waluj, Shendra andChikalthana are situated in MIDC industrial areas.
§ GlaxoSmithkline Pharmaceuticals is one of the oldest players in theIndian pharmaceuticals industry, established in 1924.
§ In 2012, the company earned revenues of INR 3.33 ThousandCrores (USD 555.4 million)
§ The company produces medicines that treats major disease areassuch as asthma, virus control, infections, mental health, diabetes anddigestive conditions.
§ The company is also a leader in the important areas of vaccines andis developing new treatments for cancer.
§ The company is headquartered at Mumbai, with manufacturingfacilities in Nashik and Thane
§ GSK India's R&D centres at Nashik have been granted recognitionby the Department of Scientific and Industrial Research,Government of India.
Wockhardt GlaxoSmithkline
16
Contact Us
Shri. Bhushan Gagrani (IAS)Chief Executive Officer - MIDCTel No : 022-26870800, 22616547
Fax No : 022-26871587Email : ceo@midcindia.org
Dr. P. Anbalagan (IAS)Joint Chief Executive Officer - MIDC
Tel : 022-26871462Fax : 022-26870026
Email: jtceo@midcindia.org
Shri. Yuvraj PomanDy. Chief Executive Officer - II
Tel : 022-26870142 ; Fax : 022-26871604Email: yuvrajpoman@midcindia.org
Head OfficeMaharashtra Industrial Development Corporation
Udyog Sarathi, Mahakali Caves Road,Andheri(E), Mumbai-400 093
DisclaimerMaharashtra Industrial Development Corporation (“MIDC”) has engaged Ernst & Young LLP. (“EY”) to prepare this document and the same has been prepared by EY in consultation with MIDC. This document is for information purposes only. While due care has been takenduring the compilation of this document to ensure that the information is accurate to the best of EY knowledge and belief, the content is not to be construed in any manner whatsoever as a substitute for professional advice.EY does not assume any liability or responsibility to any person for the outcome of decisions taken by such person as a result of any reliance placed on this presentation. EY shall not be liable for any direct or indirect damages that may arise due to any act or omission on thepart of the user due to any reliance placed or guidance taken from any portion of this presentation.© 2014All rights reserved. All copyright in this presentation and related works is solely and exclusively owned by MIDC and Ernst & Young. The same may not be reproduced, wholly or in part in any material form (including photocopying or storing it in any medium by electronicmeans and whether or not transiently or incidentally to some other use of this presentation), modified or in any manner communicated to any third party except with the written approval of MIDC.
MagneticMaharashtra
Attractions Unlimited
17
26-8
-201
4
Recommended